Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (12) , 1764-1768
- https://doi.org/10.1016/0959-8049(94)e0125-n
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Second‐line chemotherapy for recurrent carcinoma of the ovaryCancer, 1993
- Salvage Carboplatin Therapy for Advanced Ovarian Cancer After First-Line Treatment with CisplatinAmerican Journal of Clinical Oncology, 1992
- Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Salvage chemotherapy for ovarian cancer recurrence: Weekly cisplatin in combination with epirubicin or etoposideGynecologic Oncology, 1991
- Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Journal of Clinical Oncology, 1991
- Management of epithelial ovarian neoplasms using a platinum-based regimen: A 10-year experienceGynecologic Oncology, 1990
- Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agentGynecologic Oncology, 1985
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977